AI - search results

Starting in January 2020, the European REVERT project is now in its final phase. The project blends predictive medicine and AI to enable clinicians to quickly and adequately treat patients.

Bryn Sage, CEO of remote patient monitoring provider Inhealthcare, explains how the company’s digital health technology is helping to ease pressures across the NHS, reduce hospital admissions, and improve patients’ health outcomes.

Prof. Giovanni Brandi^1,2 and Dr. Simona Tavolari1 of the 1 Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; ²Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy, discuss ischemia-reperfusion injury in hepatic surgery, and the potential to prevent it through hydrogen-therapy.

A team of astronomers has identified a planet closer and younger than any other Earth-sized world.

The opioid crisis in Canada has been an issue for nearly a quarter of a century. Here, Norm Buckley and Jason Busse from the Michael G DeGroote Institute for Pain Research and Care, and the National Pain Centre discuss the issue, its effects both general and on specific communities, and what can be done about it.

In this interview, Petri Tolonen, CEO of CH-Bioforce, sheds light on the environmental benefits of Bioforsense technology.

Promoting fathers’ mental health and father involvement – a call to action is given here by Deborah Da Costa, Ph.D., Associate Professor at the Department of Medicine, McGill University, and Scientist at McGill University Health Centre.

The Algae4IBD project seeks effective treatments for a chronic disease affecting 6.8 million people. Juan F. Samaniego explores whether algae are the definitive solution for inflammatory bowel diseases.

Klaus Eyer from ETH Zurich describes high-resolution snapshots of antibody repertoires as potential correlates of protection.

Scientists have unveiled a crucial process in creating a distinctive rock type found on the Moon. This discovery highlights these lunar rocks' signature composition and presence.

Concerted efforts are needed to close knowledge gaps around mpox to improve preparedness and response efforts for this neglected disease.

Dr. Kindrachuk is an Associate Professor and Canada Research Chair in emerging and re-emerging viruses in the Departments of Medical Microbiology & Infectious Diseases and Internal Medicine, University of Manitoba His research focuses on the circulation, transmission and pathogenesis of emerging zoonotic viruses that pose the greatest threat to global...

Direct observation of neutrino production in proton-proton (pp) collisions at CERN LHC lend strong support to the Rotating Lepton Model, Constantinos G. Vayenas(1), Dionysios Tsousis(1,2) and Eftyhia Martino1 ((1)University of Patras, (2)Stanford University) tell us.

Long before the existence of microbes was known, humans were unknowingly harnessing their power through practices such as brewing, bread leavening, or cheesemaking. These processes extended the shelf life of food, enhanced its nutritional value, and significantly contributed to the advancement of industry and civilization.

With the rise of vaping continuing to increase, electronic (e-) hookahs have been advertised as a safer tobacco alternative, but it’s not all it seems.

Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?

Charles W. Carter, Jr., from the Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, relates molecular recognition used in genetic coding to structures of aminoacyl-tRNA synthetases and their cognate tRNAs.

Meeting the rapid developments in biotechnology by fostering transdisciplinarity, including digitalisation and big data, to create convergence for innovation in a virtual centre.

The World Health Organization (WHO) has certified Cabo Verde as a malaria-free country, marking a significant achievement in the global fight against the disease.

Ian is passionate about sustainable aquaculture and experienced in aquafeed innovation, marketing and sustainable development from earlier roles in industry He currently leads Global Business Development for Veramaris, an innovator of omega-3 oil from fermented algae. He holds an MBA from the University of Strathclyde in Glasgow, Scotland and has...